Al-Humaidhi AM. A review study of targeting of AAK1 and JAK1/2 using baricitinib in COVID-19 infected human cells. Al-Kindy Col. Med. J. 2020;16(supplement):9-15. doi:10.47723/kcmj.v16isupplement.176